跳至主要内容
临床试验/NCT05390229
NCT05390229招募中不适用

Comparison of the Performance of Diagnostic Contrast-enhanced Mammography and Magnetic Resonance Imaging for Suspicious Breast Lesion At Screening

CHU de Quebec-Universite Laval1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2018年12月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300
试验地点
1
主要终点
Diagnostic value for breast cancer

研究概览

简要总结

The main objective of this study is to compare the diagnostic performance of two diagnostic methods, namely CESM and MRI, in the evaluation of a lesion suspicious of breast cancer in 300 Quebec women referred for the investigation of breast cancer. breast lesion suspected of cancer. All suspicious lesions will be evaluated by these two diagnostic imaging and by TNM. Then, radiologists will respectively interpret diagnostic imaging, without knowing the result of the other imaging in parallel with the study. The sensitivity, specificity, positive predictive value and negative predictive value for his diagnostic imaging will then be determined. Histopathological confirmation by biopsy or surgery will be used as a standard value.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Female aged 18 and over
  • At least one breast lesion with BIRADS classification 5

排除标准

  • Refusal to perform the biopsy or surgery
  • Pregnant or possibly pregnant woman
  • Usual contraindication to contrast product
  • Significant kidney failure
  • Allergy to contrast medium
  • hyperthyroidism
  • Usual contraindications to MRI

结局指标

主要结局

Diagnostic value for breast cancer

时间窗: Breast cancer screening

To measure sensitivity, specificity, positive predictive value and negative predictive value for CESM and MRI using histopathological confirmation as a standard value.

Diagnostic value for suspicious breast lesion

时间窗: Breast cancer screening

To determine the ability of diagnostic imaging to identify other breast masses suspicious of cancer.

次要结局

未报告次要终点

研究者

发起方
CHU de Quebec-Universite Laval
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Screening Contrast-enhanced Mammography | 临床试验